Department Spinal of Qingdao Hospital Central, Qingdao Hospital Central, Qingdao, China.
Department Obstetrics and Gynecology of Qingdao Hospital Central, Central Qingdao Hospital, Qingdao, China.
Front Immunol. 2022 Feb 10;13:790924. doi: 10.3389/fimmu.2022.790924. eCollection 2022.
Ankylosing spondylitis (AS) is a chronic systemic autoimmune disease characterized by inflammation, bone erosion, spur formation of the spine and the sacroiliac joints. However, the etiology and molecular pathogenesis of AS remain largely unclear. Recently, a growing number of studies showed that long non-coding RNAs (lncRNAs) played critical roles in the development and progression of autoimmune and orthopedic conditions, including AS. Studies demonstrated that a myriad of lncRNAs (e.g. H19, MEG3, LOC645166) pertinent to regulation of inflammatory signals were deregulated in AS. A number of lncRNAs might also serve as new biomarkers for the diagnosis and predicting the outcomes of AS. In this review, we summarize lncRNA profiling studies on AS and the functional roles and mechanism of key lncRNAs relevant to AS pathogenesis. We also discuss their potential values as biomarkers and druggable targets for this potentially disabling condition.
强直性脊柱炎(AS)是一种慢性系统性自身免疫性疾病,其特征为炎症、骨侵蚀、脊柱和骶髂关节骨赘形成。然而,AS 的病因和分子发病机制在很大程度上仍不清楚。最近,越来越多的研究表明,长非编码 RNA(lncRNA)在自身免疫和骨科疾病(包括 AS)的发展和进展中发挥着关键作用。研究表明,与炎症信号调节相关的众多 lncRNA(如 H19、MEG3、LOC645166)在 AS 中失调。一些 lncRNA 也可能作为 AS 的诊断和预测结局的新生物标志物。在这篇综述中,我们总结了 AS 的 lncRNA 谱研究,以及与 AS 发病机制相关的关键 lncRNA 的功能作用和机制。我们还讨论了它们作为生物标志物和有治疗潜力的药物靶点的潜在价值,用于治疗这种潜在的致残性疾病。